Negative relationship between eicosapentaenoic acid and inflammatory biomarkers in patients with acute myocardial infarction.

Competing Interests: Conflict of interest: M.F. reports having received grants, consulting fees, and/or honoraria and delivering lectures for Abbott, Amarin, Amgen, AstraZeneca, Ajanta, Kowa, Merck, Novartis and Co, Organon, Pfizer, Recordati, Sanofi/Regeneron, Servier, SMB, Ultragenyx, and Viatris. F.C. reports having received non-financial support and speaking fees for Amgen, MSD, Novartis, Sanofi, and Pfizer. Y.C. reports having received consultant or speaking fees for Bayer, BMS/Pfizer, Boehringer Ingelheim, Novartis, Sanofi, and Servier. M.Z. declares research grants from Amarin Corp. and lecture fees from Organon. The other authors have no declaration.